Cargando…
Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension
BACKGROUND: COVID-19 pandemic severely affected national health systems, altering the modality and the type of care of patients with acute and chronic diseases. To minimize the risk of exposure to SARS-CoV2 for patients and health professionals, face-to-face visits were cancelled or postponed and th...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212864/ https://www.ncbi.nlm.nih.gov/pubmed/35716991 http://dx.doi.org/10.1016/j.vph.2022.107024 |
_version_ | 1784730703902015488 |
---|---|
author | Manzi, Giovanna Papa, Silvia Mariani, Marco Valerio Scoccia, Gianmarco Filomena, Domenico Malerba, Claudia Adamo, Francesca Ileana Caputo, Annalisa De Lazzari, Claudio De Lazzari, Beatrice Cedrone, Nadia Madonna, Rosalinda Recchioni, Tommaso Serino, Giorgia Vizza, Carmine Dario Badagliacca, Roberto |
author_facet | Manzi, Giovanna Papa, Silvia Mariani, Marco Valerio Scoccia, Gianmarco Filomena, Domenico Malerba, Claudia Adamo, Francesca Ileana Caputo, Annalisa De Lazzari, Claudio De Lazzari, Beatrice Cedrone, Nadia Madonna, Rosalinda Recchioni, Tommaso Serino, Giorgia Vizza, Carmine Dario Badagliacca, Roberto |
author_sort | Manzi, Giovanna |
collection | PubMed |
description | BACKGROUND: COVID-19 pandemic severely affected national health systems, altering the modality and the type of care of patients with acute and chronic diseases. To minimize the risk of exposure to SARS-CoV2 for patients and health professionals, face-to-face visits were cancelled or postponed and the use of telemedicine was strongly encouraged. This reorganization involved especially patients with rare diseases needing periodic comprehensive assessment, such as pulmonary arterial hypertension (PAH). MAIN BODY: The paper reports a proposal of strategy adopted for patients followed at our PAH center in Rome, where patients management was diversified based on clinical risk according to the European Society of Cardiology/European Respiratory Society PH guidelines-derived score and the REVEAL 2.0 score. A close monitoring and support of these patients were made possible by policy changes reducing barriers to telehealth access and promoting the use of telemedicine. Synchronous/asynchronous modalities and remote monitoring were used to collect and transfer medical data in order to guide physicians in therapeutic-decision making. Conversely, the use of implantable monitors providing hemodynamic information and echocardiography-mobile devices wirelessly connecting was limited by the poor experience existing in this setting. Large surveys and clinical trials are welcome to test the potential benefit of the optimal balance between traditional PAH management and telemedicine opportunities. CONCLUSION: Italy was found unprepared to manage the dramatic effects caused by COVID-19 on healthcare systems. In this emergency situation telemedicine represented a promising tool especially in rare diseases as PAH, but was limited by its scattered availability and legal and ethical issues. Cohesive partnership of health care providers with regional public health officials is needed to prioritize PAH patients for telemedicine by dedicated tools. |
format | Online Article Text |
id | pubmed-9212864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92128642022-06-22 Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension Manzi, Giovanna Papa, Silvia Mariani, Marco Valerio Scoccia, Gianmarco Filomena, Domenico Malerba, Claudia Adamo, Francesca Ileana Caputo, Annalisa De Lazzari, Claudio De Lazzari, Beatrice Cedrone, Nadia Madonna, Rosalinda Recchioni, Tommaso Serino, Giorgia Vizza, Carmine Dario Badagliacca, Roberto Vascul Pharmacol Article BACKGROUND: COVID-19 pandemic severely affected national health systems, altering the modality and the type of care of patients with acute and chronic diseases. To minimize the risk of exposure to SARS-CoV2 for patients and health professionals, face-to-face visits were cancelled or postponed and the use of telemedicine was strongly encouraged. This reorganization involved especially patients with rare diseases needing periodic comprehensive assessment, such as pulmonary arterial hypertension (PAH). MAIN BODY: The paper reports a proposal of strategy adopted for patients followed at our PAH center in Rome, where patients management was diversified based on clinical risk according to the European Society of Cardiology/European Respiratory Society PH guidelines-derived score and the REVEAL 2.0 score. A close monitoring and support of these patients were made possible by policy changes reducing barriers to telehealth access and promoting the use of telemedicine. Synchronous/asynchronous modalities and remote monitoring were used to collect and transfer medical data in order to guide physicians in therapeutic-decision making. Conversely, the use of implantable monitors providing hemodynamic information and echocardiography-mobile devices wirelessly connecting was limited by the poor experience existing in this setting. Large surveys and clinical trials are welcome to test the potential benefit of the optimal balance between traditional PAH management and telemedicine opportunities. CONCLUSION: Italy was found unprepared to manage the dramatic effects caused by COVID-19 on healthcare systems. In this emergency situation telemedicine represented a promising tool especially in rare diseases as PAH, but was limited by its scattered availability and legal and ethical issues. Cohesive partnership of health care providers with regional public health officials is needed to prioritize PAH patients for telemedicine by dedicated tools. Elsevier Inc. 2022-08 2022-06-16 /pmc/articles/PMC9212864/ /pubmed/35716991 http://dx.doi.org/10.1016/j.vph.2022.107024 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Manzi, Giovanna Papa, Silvia Mariani, Marco Valerio Scoccia, Gianmarco Filomena, Domenico Malerba, Claudia Adamo, Francesca Ileana Caputo, Annalisa De Lazzari, Claudio De Lazzari, Beatrice Cedrone, Nadia Madonna, Rosalinda Recchioni, Tommaso Serino, Giorgia Vizza, Carmine Dario Badagliacca, Roberto Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension |
title | Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension |
title_full | Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension |
title_fullStr | Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension |
title_full_unstemmed | Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension |
title_short | Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension |
title_sort | telehealth: a winning weapon to face the covid-19 outbreak for patients with pulmonary arterial hypertension |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212864/ https://www.ncbi.nlm.nih.gov/pubmed/35716991 http://dx.doi.org/10.1016/j.vph.2022.107024 |
work_keys_str_mv | AT manzigiovanna telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT papasilvia telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT marianimarcovalerio telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT scocciagianmarco telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT filomenadomenico telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT malerbaclaudia telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT adamofrancescaileana telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT caputoannalisa telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT delazzariclaudio telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT delazzaribeatrice telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT cedronenadia telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT madonnarosalinda telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT recchionitommaso telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT serinogiorgia telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT vizzacarminedario telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension AT badagliaccaroberto telehealthawinningweapontofacethecovid19outbreakforpatientswithpulmonaryarterialhypertension |